MerLoin granted Alcon exclusive, North American development and commercialization rights to topical finafloxacin to treat ear infections

MerLion Pharmaceuticals Pte. Ltd.

Singapore / Tools, Services, and Manufacturing

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Alcon Inc.

Switzerland / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced